BioSpace News Archive

Press Releases

AusperBio Raises $63 Million in Series B2 Financing to Accelerate Functional Cure Therapies for Chronic Hepatitis B

September 22, 2025
·
3 min read
Press Releases

C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting

September 22, 2025
·
12 min read
Press Releases

Stealth BioTherapeutics Announces FDA Accelerated Approval of FORZINITY™ (elamipretide HCl), the First Therapy for Progressive and Life-limiting Ultra-rare Genetic Disease Barth Syndrome

September 22, 2025
·
7 min read
Press Releases

FDA Approves Merck’s KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) Injection for Subcutaneous Use in Adults Across Most Solid Tumor Indications for KEYTRUDA® (pembrolizumab)

September 22, 2025
·
19 min read
Press Releases

Onco-Innovations Commences Activities to Manufacture Nanoparticle Formulation with Dalton Pharma to Supply Preclinical Animal Studies

September 22, 2025
·
3 min read
Press Releases

TREMFYA® (guselkumab) achieves U.S. approval for subcutaneous induction in adults with ulcerative colitis, now the first and only IL-23 inhibitor with a fully subcutaneous regimen

September 22, 2025
·
20 min read
Press Releases

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - September 19, 2025

September 22, 2025
·
3 min read
Press Releases

Olympus Issues Voluntary Recall for Specific Lots of ViziShot 2 FLEX (19G) EBUS -TBNA Needles

September 22, 2025
·
2 min read
Press Releases

Revive Therapeutics Announces Closing of Second Tranche of Private Placement

September 22, 2025
·
3 min read
Press Releases

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - September 19, 2025

September 22, 2025
·
1 min read